Giancarlo Comi
Comi, Giancarlo, 1947-....
Comi, Giancarlo
Comi, G. (Giancarlo), 1947-
Comi, G. 1947-
Comi, G. (Giancarlo)
VIAF ID: 22362932 (Personal)
Permalink: http://viaf.org/viaf/22362932
Preferred Forms
- 200 _ 1 ‡a Comi ‡b , Giancarlo
-
- 100 1 _ ‡a Comi, G. ‡d 1947-
- 100 1 _ ‡a Comi, G. ‡q (Giancarlo)
-
- 100 1 0 ‡a Comi, G. ‡q (Giancarlo), ‡d 1947-
-
-
-
- 100 1 _ ‡a Comi, Giancarlo ‡d 1947-
- 100 1 _ ‡a Comi, Giancarlo ‡d 1947-
-
- 100 1 _ ‡a Comi, Giancarlo, ‡d 1947-....
- 100 0 _ ‡a Giancarlo Comi
4xx's: Alternate Name Forms (10)
Works
Title | Sources |
---|---|
Bezpieczeństwo i skuteczność doustnej kladrybiny u pacjentów z rzutowo-remisyjną postacią stwardnienia rozsianego : wyniki randomizowanej kontynuacji badania CLARITY | |
Długoterminowe bezpieczeństwo i tolerancja octanu glatirameru w dawce 20 mg w leczeniu nawrotowych postaci stwardnienia rozsianego | |
Early indicators, early treatments, neuroprotection in multiple sclerosis | |
Efectos del tratamiento precoz con acetato de glatiramero en pacientes con síndrome clínico aislado | |
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome | |
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial | |
Induction and add-on therapy with mitoxantrone and interferon beta in multiple sclerosis | |
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial | |
Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. | |
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis. | |
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease. | |
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF. | |
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis. | |
Laser capture microdissection for transcriptomic profiles in human skin biopsies. | |
Lombardia GENS: a collaborative registry for monogenic diseases associated with stroke. | |
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients | |
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study | |
Long-term safety and tolerability of glatiramer acetate 20 mg in the treatment of relapsing forms of multiple sclerosis | |
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide | |
Magnetic resonance techniques in clinical trials in multiple sclerosis | |
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. | |
Manuale di neurofisiologia diagnostica / Massimo Franceschi, Giancarlo Comi, Salvatore Smirne | |
Mapping early changes of cortical motor output after subcortical stroke: a transcranial magnetic stimulation study. | |
Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study | |
Metallothioneins as dynamic markers for brain disease in lysosomal disorders | |
Monoclonal Antibodies Conjugated with Superparamagnetic Iron Oxide Particles Allow Magnetic Resonance Imaging Detection of Lymphocytes in the Mouse Brain | |
Motor evoked potentials in a mouse model of chronic multiple sclerosis | |
Motor learning in healthy humans is associated to gray matter changes: a tensor-based morphometry study | |
Movement-related event-related desynchronization in neuropsychiatric disorders | |
Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice | |
MR Imaging of Brachial Plexus and Limb-Girdle Muscles in Patients with Amyotrophic Lateral Sclerosis. | |
MRI and Multiple Sclerosis: What Happened in the Last 10 Years? | |
MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction | |
Multimodal structural MRI in the diagnosis of motor neuron diseases | |
Multiple sclerosis : recovery of function and neurorehabilitation | |
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies | |
Myeloid cells as target of fingolimod action in multiple sclerosis | |
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. | |
Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease | |
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies | |
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood. | |
Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders | |
Neurologia clinica / David A. Greenberg, Michael J. Aminoff, Roger P. Simon ; edizione italiana a cura di Giancarlo Comi | |
Neurophysiological markers | |
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial | |
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis | |
No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. | |
No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a. | |
Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick's disease pathology | |
Noninvasive Neuromodulation in Poststroke Gait Disorders: Rationale, Feasibility, and State of the Art. | |
Normal-appearing white and grey matter damage in multiple sclerosis | |
Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. | |
Octan glatirameru i jego zastosowanie w stwardnieniu rozsianym = The heritage of glatiramer acetate and its in multiple sclerosis | |
Ocular pain: a neurological perspective | |
Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal-trigeminal axis. | |
Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease | |
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis | |
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. | |
Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. | |
P2X7 receptor is expressed in human vessels and might play a role in atherosclerosis. | |
Parkinsonism and aging | |
Patent foramen ovale closure and brain ischaemic lesions | |
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study | |
Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study | |
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity | |
potenziali evocati nella sclerosi multipla diagnosi, prognosi e monitoraggio | |
Primary progressive multiple sclerosis | |
Rozpoznawanie stwardnienia rozsianego : aktualizacja kryteriów McDonalda w 2017 roku = Diagnosis of multiple sclerosis : 2017 revisions of the McDonald criteria | |
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis : results from the randomized extension trial of the CLARITY study | |
Sclerosi multipla e malattie demielinizzanti del sistema nervoso centrale : nuovi orizzonti / Giancarlo Comi | |
Topics in the neurosciences | |
A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. | |
Zmieniające się koncepcje terapeutyczne w nawrotowej postaci stwardnienia rozsianego |